Cost-effectiveness of eplerenone in NYHA class II chronic heart failure patients with reduced LVEF: an analysis for Greece

Overview of attention for article published in ClinicoEconomics and Outcomes Research: CEOR, October 2016

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (65th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

policy: 1 policy source

twitter: 1 X user

Citations

dimensions_citation: 5 Dimensions

Readers on

mendeley: 24 Mendeley

Summary Policy documents X Dimensions citations

So far, Dimensions has found 5 publications that cite this research output.

5

The most recent citing publications are shown below. View all 5 publications that cite this research output on Dimensions.

Economic Evaluations of Guideline-Directed Medical Therapies for Heart Failure With Reduced Ejection Fraction: A Systematic Review

Article in Value in Health (May 2023)

Does a Standard Cost-Effectiveness Threshold Exist? The Case of Greece

Article in Value in Health Regional Issues (March 2023)

The relevance of prescribing triple neurohormonal blockade in real clinical practice: the role of mineralocorticoid receptor antagonists

Article in Consilium Medicum (January 2021)